October 05 - 09:10
Artrya cleared to bring AI heart disease detection tool to market in Australia
Artrya will market its AI heart disease detection tool in Australia early next year after satisfying regulators. The tool, called "Salix", creates a 3D image of a patient's heart and generates an assessment of issues within 15 minutes. Salix has been developed in partnership with researchers from the University of Western Australia. Artrya is set to raise as much as $40m from an IPO next month.
> Tweets